CST 2.63% 7.8¢ castile resources ltd

?Adding content: Expanding biomarker portfolio in Personalized...

  1. 1,948 Posts.
    ?Adding content: Expanding biomarker portfolio in Personalized Healthcare; products from Cellestis and Ipsogen acquisitions contribute to growth in second half of 2011

    http://www.prnewswire.com/news-releases/qiagen-reports-fourth-quarter-and-full-year-2011-results-138428014.html
 
watchlist Created with Sketch. Add CST (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.